Security key
G9008W113
Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW)
CUSIP: G9008W113
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / *W EXP 12/18/202
- Total 13F shares
- 7,305,240
- Total 13F value
- $2,127,339
- Share change
- +44,949
- SEC-reported price per share
- $0.29
- Number of holders
- 33
- Value change
- +$15,660
- Number of buys
- 5
- Number of sells
- 12
Report period
Q3 2025
Institutions
33
Top holders
10
TDACW full security history
Ownership snapshot
Full 13F holder table
Translational Development Acquisition Corp. SEC filings
Translational Development Acquisition Corp. company facts
Broader feeds
Ownership snapshot
Top reported holders of TDACW - Translational Development Acquisition Corp. - *W EXP 12/18/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Magnetar Financial LLC
Disclosed value leader
WOLVERINE ASSET MANAGEMEN...
Comparable rows
4/15
Latest evidence
30 Jun 2025
13F
13D/G
Lead comparable stake: 7.5%
11 rows are not safely comparable across share classes.
13D/G row: Magnetar Financial LLC
Showing 1-6 of 15 holder rows.
Quick read
Magnetar Financial LLC leads the comparable SEC ownership view at 7.5%.
4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Magnetar Financial LLC's linked filing trail.
Comparable ownership
Top 4
Magnetar Financial LLC
7.5%
AQR CAPITAL MANAGEMENT LLC
6.4%
BANK OF MONTREAL /CAN/
4.6%
HEALTHCARE OF ONTARIO PENSION PLA...
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Magnetar Financial LLC |
13F
13D/G
Company
|
7.5%
Reported 13D/G
· 31 Dec 2024
|
$13,526,370
1,950,000 shares
mixed-class rows
|
— | 30 Jun 2025 |
| AQR CAPITAL MANAGEMENT LLC |
13D/G
|
6.4%
Reported 13D/G
· 31 Mar 2025
|
$11,087,889
1,099,989 shares
|
-$3,880,911 | 31 Mar 2025 |
| BANK OF MONTREAL /CAN/ |
13D/G
Bank of Montreal
|
4.6%
Reported 13D/G
· 30 Jun 2025
|
$8,240,000
800,000 shares
|
-$2,060,000 | 30 Jun 2025 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13D/G
13F
Company
|
2.3%
Reported 13D/G
· 31 Mar 2025
|
$4,032,000
400,000 shares
|
-$5,040,000 | 31 Mar 2025 |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
Company
|
—
mixed-class rows
|
$13,992,129
1,509,691 shares
mixed-class rows
|
— | 30 Jun 2025 |
| AQR Arbitrage LLC |
13F
Company
|
—
mixed-class rows
|
$11,515,808
1,842,486 shares
mixed-class rows
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
33
Shares
7,305,240
Rows available
33
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
29
Q3 2025 holders
33
Holder diff
4
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|